Alternate text
 

Pediatric Research

Dear Duke Pediatrics Colleagues,

The following are new and competitive renewal research awards made to investigators in the Duke Department of Pediatrics through the months of September and October 2025.  These awards represent the successful culmination of work from numerous members of Duke Pediatrics covering exciting basic, translational, and clinical research. Please extend your congratulations to the following faculty members and their research teams.

Thank you,

Marsha Newby, Senior Grants and Contracts Manager

Christoph Hornik, MD PhD MPH, Vice Chair Research

 

September 2025 Awardees

 

Bruno Chumpitazi, MD, MPH

Instructor Temporary in the Department of Pediatrics, Gastroenterology

Phase 3 Study to Assess the Safety and Efficacy of Tenapanor

Ardelyx, Inc.

09/07/2025-10/01/2027

 

Rasheed Gbadegesin, MBBS

Wilburt C. Davison Distinguished Professor Professor of Pediatrics, Nephrology

Phase 2b Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants with APOL1-Mediated Kidney Disease (APPRECIATE)

AstraZeneca AB

09/17/2025-12/17/2029

 

Rebecca Koch, PhD

Assistant Professor of Pediatrics, Medical Genetics

Assessment of GYS1 Knockdown on Pompe Disease

Alnylam U.S., Inc.

09/06/2025-09/30/2026

 

Andrew Landstrom, MD, PhD

Professor of Pediatrics, Cardiology

Jennifer Li, MD

Beverly C. Morgan, M.D., Distinguished Professor of Pediatric of Pediatrics, Cariology

T32 Institutional Training Grant

iPediHeart: Interdisciplinary Research Training Program for Pediatric Heart Disease

National Institutes of Health/ NHLBI

09/01/2025-08/31/2030

 

Brian Smith, MD, MHS, MPH

Samuel L. Katz Distinguished Professor of Pediatrics Professor of Pediatrics, Neonatology

U2C Supplemental Award

ECHO Coordinating Center- Kitting Expanded Scope

National Institute of Health

08/01/2025-05/31/2026

 

Jessica Sun, MD, PhD

Associate Professor of Pediatrics, Hematology-Oncology

SOG Trial S1826 - Children’s Oncology Group Foundation/Hope Foundation for Cancer Research (07/01/2025-06/30/2026)

AALL1732 - Public Health Institute/Servier Pharmaceuticals LLC (03/17/2025-06/16/2028)

 

Muhammad Zafar, MBBS

Associate Professor of Pediatrics, Neurology

Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Therapy in Patients with Lennox-Gastaut

Epygenix Therapeutics Inc.

09/23/2025-07/03/2028

 

October 2025 Awardees

 

Sarah Armstrong, MD

Professor of Pediatrics, General Pediatrics and Adolescent Health

Are Interventions Supporting Physical Activity Modified by the Environment (InSpace)

Seattle Children’s Research Institute/National Institutes of Health

07/01/2025-04/30/2026

 

Michael Jay Campbell, MD

Professor of Pediatrics, Cardiology

Outcome Measures for DMD Drug Trials Fixed Rate

Vanderbilt University Medical Center/National Institutes of Health

09/01/2025-06/30/2030

 

Rasheed Gbadegesin, MBBS

Wilburt C. Davison Distinguished Professor Professor of Pediatrics, Nephrology

APOL1-Associated Nephropathy from Human-Derived, Intrarenal Perspective

Boston Children’s Hospital/National Institutes of Health

09/01/2025-06/30/2030

 

Natalie Katz, MD

Assistant Professor of Pediatrics, Neurology

A Long-term Multicenter Prospective Observational Study Evaluating the Comparative Effectiveness and Safety of Sarepta Gene Transfer Therapy vs. Standard of Care in Participants with Duchenne Muscular Dystrophy

Sarepta Therapeutics, Inc.

10/01/2025-12/31/2035

 

Priya Kishnani, MBBS

Chen Family Distinguished Professor of Pediatrics, Medical Genetics

Pompe Case Report

Amicus Therapeutics, Inc.

10/16/2025-08/31/2026

 

Andrew Landstrom, MD, PhD

Professor of Pediatrics, Cardiology

IPRISM (Imaging-Enhanced Prediction of Risk for Sudden Cardiac Death in HcM

Oregon Health and Science University/National Institutes of Health

07/01/2025-06/30/2029

 

Kris Mahadeo, MD

Professor of Pediatrics, Transplant and Cellular Therapy

Phase 1/2 Open-Label, Single-Ascending-Dose Study of EN-374, a Helper-Dependent Adenoviral-Based Gene Therapy, in Participants with X-Linked Chronic Granulomatous Disease - Ensoma Inc. (09/16/2025-12/31/2027)

JMML Allogeneic Hematopoietic Cell Transplantation - University of California-San Francisco (01/01/2025-12/31/2025)

 

Niraj Patel, MD

Associate Professor of Pediatrics, Allergy and Immunology

A Phase III, Open-label, Prospective, Multicenter Study to Assess Efficacy, Safety of Kedrion

Kedrion S.p.A.

10/10/2025-04/05/2027

 

Jessica Sun, MD, PhD

Associate Professor of Pediatrics, Hematology-Oncology

AR66913: PEPN1924 Leidos Site Correlative Services

Public Health Institute/Leidos Biomedical Research, Inc.

08/31/2021-08/30/2025

 

Emmanuel Walter, MD, MPH

Professor of Pediatrics, Infectious Diseases

CIVICs C Option 8B Phase 1 Equitable Adjustment (EA)

National Institutes of Health

02/22/2021-09/15/2026

 

Charles Wood, MD, MPH

Associate Professor of Pediatrics, General Pediatrics and Adolescent Health

Evaluating EHR-based Prediction of Obesity using WHO Weight Velocity Standards and Peak BMI

Cincinnati Children’s Hospital

09/01/2025-08/31/2027

 
Sign up for this Newsletter

Questions or feedback on this newsletter or its contents, please contact:

PediatricResearch@duke.edu

Duke Department of Pediatrics

pediatrics.duke.edu/research

Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.

2400 Pratt Street | Durham, NC 27710 US

This email was sent to pediatricresearch@dm.duke.edu.
To continue receiving our emails, add us to your address book.